Gentian violet solution for staining the anterior capsule

Basit Öğe Kaydı
dc.contributor.authorÜnlü, K
dc.contributor.authorAskünger, A
dc.contributor.authorSöker, S
dc.contributor.authorKilinç, N
dc.contributor.authorKaraca, C
dc.contributor.authorErdinc, M
dc.date.accessioned2024-04-24T16:18:53Z
dc.date.available2024-04-24T16:18:53Z
dc.date.issued2000
dc.departmentDicle Üniversitesien_US
dc.descriptionXIIth Congress of the European-Society-of-Ophthalmology -- JUL, 1999 -- STOCKHOLM, SWEDENen_US
dc.description.abstractPurpose: To evaluate the histopathological changes after injecting gentian violet solution into the anterior chamber of rats and to describe a technique that uses gentian violet to allow a clear view of the anterior capsule during continuous curvilinear capsulorhexis (CCC) in human eyes with white mature cataract. Setting: Department of Ophthalmology, University of Dicle, Diyarbakir, Turkey. Methods In this masked, experimental study (first stage), 0.05 mL of gentian violet 0.01% or 0.001% solution or balanced salt solution (BSS(R)) (control group) was injected into the anterior chamber of 30 eyes of 30 Wistar albino rats. One, 24, and 48 hours after injection, 4 eyes in each group and 2 eyes in the control group were enucleated, and histopathological examination was performed. In the second stage, these solutions were used for staining the anterior capsule in the 18 human eyes with white mature cataract. The success rate of CCC and intraoperative and postoperative complications were evaluated. Results: Histopathological examination revealed no pathology in any group. A CCC was completed in all cases. No intraoperative or postoperative complications were observed in human eyes except mild corneal edema and mild inflammatory reaction in the anterior chamber that improved within 1 week. Mean follow-up was 3.4 months. Visualization of the anterior capsule was better with gentian violet 0.01% solution. Conclusions: Gentian violet solutions at 0.01% and 0.001% concentrations had no evident toxic effect that caused significant histopathological changes. The staining technique was practical and helped the surgeon visualize the anterior capsule. However, gentian violet may have adverse effects that lead to corneal edema. J Cataract Refract Surg 2000; 26:. 1228-1232 (C) 2000 ASCRS and ESCRS.en_US
dc.description.sponsorshipEuropean Soc Ophthalmolen_US
dc.identifier.doi10.1016/S0886-3350(00)00360-6
dc.identifier.endpage1232en_US
dc.identifier.issn0886-3350
dc.identifier.issue8en_US
dc.identifier.pmid11008053
dc.identifier.scopus2-s2.0-0033805371
dc.identifier.scopusqualityQ1
dc.identifier.startpage1228en_US
dc.identifier.urihttps://doi.org/10.1016/S0886-3350(00)00360-6
dc.identifier.urihttps://hdl.handle.net/11468/16319
dc.identifier.volume26en_US
dc.identifier.wosWOS:000089468800031
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherAmer Soc Cataract Refractive Surgeryen_US
dc.relation.ispartofJournal of Cataract and Refractive Surgery
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keyword]en_US
dc.titleGentian violet solution for staining the anterior capsuleen_US
dc.titleGentian violet solution for staining the anterior capsule
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu